Evolutionary Insulin Management: A Digital Health Solutions for Type 1 Diabetes Support

Type 1 diabetes is characterised by a deficiency of pancreatic beta cells, resulting in hyperglycemia and insulin deficiency. It usually develops during childhood or adolescence, but symptoms can appear much later. The specific origin of type 1 diabetes is still unknown, but T cell-mediated beta cell death is thought to be responsible for the monogenesis of the disease. New treatments such as insulin pumps, continuous glucose monitoring and hybrid closed-loop systems are being developed. Tight glycemic control has reduced the incidence of microvascular and macrovascular disorders. However, most T1DM patients continue to experience these problems and significant research efforts are needed to improve the quality of life and prognosis of T1DM patients through early diagnosis, prevention of beta cell depletion and better treatment options. Exogenous insulin therapy is needed in this disease to avoid the devastating consequences of hyperglycemia. Psychological issues and comorbidity management are elements of good T1D care, proper nutrition, diabetes treatment, and comprehensive diabetes education. Additionally, several challenges must be overcome at different stages of life. Managing T1D with limited resources Healthcare professionals deal with various difficulties at work. Nonetheless, an alphabetical approach can achieve the best outcome and enable comprehensive T1D care in a scenario where resources are scarce. In the management of children with type 1 diabetes mellitus (T1DM), effective glycemic control is crucial since it is associated with improved short- and long-term health outcomes. However, poor glycemic control lowers quality of life and increases the risk of acute and chronic issues.